×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NDAQ – nasdaq, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NDAQ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/12
08:00 pm
ndaq
Annual Changes to the Nasdaq-100 Index®
Neutral
Report
Annual Changes to the Nasdaq-100 Index®
12/12
02:03 pm
ndaq
Nasdaq Moves to Block Risky IPOs as Microcap Chaos Draws Regulator Fire [Yahoo! Finance]
Low
Report
Nasdaq Moves to Block Risky IPOs as Microcap Chaos Draws Regulator Fire [Yahoo! Finance]
12/12
10:54 am
ndaq
Anabranch Capital Management, LP supports relisting of SmartCraft ASA to Nasdaq Stockholm [Yahoo! Finance]
Low
Report
Anabranch Capital Management, LP supports relisting of SmartCraft ASA to Nasdaq Stockholm [Yahoo! Finance]
12/12
07:12 am
ndaq
Nasdaq (NASDAQ:NDAQ) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Nasdaq (NASDAQ:NDAQ) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/11
04:15 am
ndaq
Invitation to conference call with web presentation of SkiStar AB's Interim Report for the First Quarter 2025/26 [Yahoo! Finance Canada]
Low
Report
Invitation to conference call with web presentation of SkiStar AB's Interim Report for the First Quarter 2025/26 [Yahoo! Finance Canada]
12/11
03:18 am
ndaq
Karolinska Development's portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D [Yahoo! Finance]
Low
Report
Karolinska Development's portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D [Yahoo! Finance]
12/10
07:12 am
ndaq
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia [Yahoo! Finance]
Low
Report
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia [Yahoo! Finance]
12/10
03:56 am
ndaq
Karolinska Development's portfolio company AnaCardio presents positive top-line data from the phase 2a study of its drug candidate AC01 [Yahoo! Finance]
Low
Report
Karolinska Development's portfolio company AnaCardio presents positive top-line data from the phase 2a study of its drug candidate AC01 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
04:04 pm
ndaq
Form 4 NASDAQ, INC. For: Dec 06 Filed by: SKULE JEREMY
Low
Report
Form 4 NASDAQ, INC. For: Dec 06 Filed by: SKULE JEREMY
12/9
04:01 pm
ndaq
Form 4 NASDAQ, INC. For: Dec 06 Filed by: Youngwood Sarah
Low
Report
Form 4 NASDAQ, INC. For: Dec 06 Filed by: Youngwood Sarah
12/3
04:08 pm
ndaq
Form 4 NASDAQ, INC. For: Dec 01 Filed by: Smith Bryan Everard
Low
Report
Form 4 NASDAQ, INC. For: Dec 01 Filed by: Smith Bryan Everard
12/3
04:06 pm
ndaq
Form 4 NASDAQ, INC. For: Dec 01 Filed by: SKULE JEREMY
Low
Report
Form 4 NASDAQ, INC. For: Dec 01 Filed by: SKULE JEREMY
12/1
04:17 pm
ndaq
Form 8-K NASDAQ, INC. For: Dec 01
Low
Report
Form 8-K NASDAQ, INC. For: Dec 01
12/1
04:05 pm
ndaq
Form 144 NASDAQ, INC. Filed by: Smith Bryan Everard
Low
Report
Form 144 NASDAQ, INC. Filed by: Smith Bryan Everard
12/1
04:03 pm
ndaq
Form 144 NASDAQ, INC. Filed by: SKULE JEREMY
Low
Report
Form 144 NASDAQ, INC. Filed by: SKULE JEREMY
11/5
04:00 pm
ndaq
Form 4 NASDAQ, INC. For: Nov 03 Filed by: SKULE JEREMY
Low
Report
Form 4 NASDAQ, INC. For: Nov 03 Filed by: SKULE JEREMY
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Nasdaq Inc (NASDAQ: NDAQ) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
13.9%
3/25 Nasdaq Pledges Business and Philanthropic Support in Response to COVID-19 7.9%
3/30 Nasdaq Inc (NASDAQ: NDAQ) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.2%
4/3 Form 4 NASDAQ, INC. For: Apr 01 Filed by: Tal Cohen 6.9%
3/13 Nasdaq adjusts stock reopening procedure after coronavirus volatility [Reuters (UK)] 5.9%
3/3 Nasdaq February 2020 Volumes 5.7%
4/24 Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2020 5.7%
3/24 Nasdaq Scheduled Resumption in Golden Bull Limited 5.0%
4/8 NASDAQ MARCH 2020 VOLUMES, 1Q20 ESTIMATED REVENUE CAPTURE AND LISTINGS STATISTICS 3.6%
6/5 Nasdaq Joins Microsoft to Increase Access to Real-Time U.S. Equity Market Data 3.4%
3/25 Nasdaq Pledges Business and Philanthropic Support in Response to COVID-19 7.9%
3/30 Nasdaq Inc (NASDAQ: NDAQ) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.2%
4/3 Form 4 NASDAQ, INC. For: Apr 01 Filed by: Tal Cohen 6.9%
3/13 Nasdaq adjusts stock reopening procedure after coronavirus volatility [Reuters (UK)] 5.9%
3/3 Nasdaq February 2020 Volumes 5.7%
4/24 Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2020 5.7%
3/24 Nasdaq Scheduled Resumption in Golden Bull Limited 5.0%
4/8 NASDAQ MARCH 2020 VOLUMES, 1Q20 ESTIMATED REVENUE CAPTURE AND LISTINGS STATISTICS 3.6%
6/5 Nasdaq Joins Microsoft to Increase Access to Real-Time U.S. Equity Market Data 3.4%
TOP News Decliners
3/15
Nasdaq Statement on North American Operations
-12.1%
3/11 Nasdaq Scheduled Resumption in Borqs Technologies Inc. -10.8%
4/22 Nasdaq Inc (NASDAQ: NDAQ) had its "buy" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $120.00 price target on the stock. -6.2%
3/10 Form 4 NASDAQ, INC. For: Mar 06 Filed by: SKULE JEREMY -5.4%
2/26 Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 14, 2020 -4.9%
9/9 Form 4 NASDAQ, INC. For: Sep 05 Filed by: Griggs PC Nelson -4.6%
2/27 Form 4 NASDAQ, INC. For: Feb 25 Filed by: Tal Cohen -4.4%
3/6 Delisting of Securities of CPI Card Group Inc. and Valeritas Holdings, Inc. from The Nasdaq Stock Market -4.3%
4/9 Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2020 -4.3%
4/20 Delisting of Securities of Internap Corporation and Paringa Resources Limited from The Nasdaq Stock Market -4.1%
3/11 Nasdaq Scheduled Resumption in Borqs Technologies Inc. -10.8%
4/22 Nasdaq Inc (NASDAQ: NDAQ) had its "buy" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $120.00 price target on the stock. -6.2%
3/10 Form 4 NASDAQ, INC. For: Mar 06 Filed by: SKULE JEREMY -5.4%
2/26 Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 14, 2020 -4.9%
9/9 Form 4 NASDAQ, INC. For: Sep 05 Filed by: Griggs PC Nelson -4.6%
2/27 Form 4 NASDAQ, INC. For: Feb 25 Filed by: Tal Cohen -4.4%
3/6 Delisting of Securities of CPI Card Group Inc. and Valeritas Holdings, Inc. from The Nasdaq Stock Market -4.3%
4/9 Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2020 -4.3%
4/20 Delisting of Securities of Internap Corporation and Paringa Resources Limited from The Nasdaq Stock Market -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: